Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to NAVIGEN, INC.

where

SBIR/STTR Award Recipient

‌

NAVIGEN, INC.

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ NAVIGEN, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to NAVIGEN, INC. in September, 2018 for $323,066.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NAVIGEN, INC.	National Institutes of Health	SBIR	1R43DK117777-01	Phase I	323,066	September 18, 2018	sbir.gov/node/1567567
‌ NAVIGEN, INC. SBIR Phase II Award, April 2020	A SBIR Phase II contract was awarded to NAVIGEN, INC. in April, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NAVIGEN, INC.	National Institutes of Health	SBIR	2U44AI095172-08	Phase II	1,000,000	April 25, 2020	sbir.gov/node/1908823
‌ NAVIGEN, INC. SBIR Phase I Award, August 2018	A SBIR Phase I contract was awarded to NAVIGEN, INC. in August, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NAVIGEN, INC.	National Institutes of Health	SBIR	1R43AI141129-01	Phase I	300,000	August 3, 2018	sbir.gov/node/1570315
‌ NAVIGEN, INC. SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to NAVIGEN, INC. in September, 2019 for $268,075.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NAVIGEN, INC.	National Institutes of Health	SBIR	1R43HL147780-01	Phase I	268,075	September 24, 2019	sbir.gov/node/1681775
‌ NAVIGEN, INC. SBIR Phase II Award, September 2014	A SBIR Phase II contract was awarded to NAVIGEN, INC. in September, 2014 for $1,502,644.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44AR063509-02	Phase II	1,502,644	September 1, 2014	sbir.gov/node/1046319
‌ NAVIGEN, INC. SBIR Phase II Award, March 2015	A SBIR Phase II contract was awarded to NAVIGEN, INC. in March, 2015 for $2,894,941.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44AI102347-03	Phase II	2,894,941	March 16, 2015	sbir.gov/node/1031265
‌ NAVIGEN, INC. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to NAVIGEN, INC. in September, 2017 for $299,945.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43CA224710-01	Phase I	299,945	September 19, 2017	sbir.gov/node/1323081
‌ NAVIGEN, INC. SBIR Phase II Award, August 2016	A SBIR Phase II contract was awarded to NAVIGEN, INC. in August, 2016 for $2,992,259.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44AI098197-03A1	Phase II	2,992,259	August 1, 2016	sbir.gov/node/1198357
‌ NAVIGEN, INC. SBIR Phase I Award, July 2015	A SBIR Phase I contract was awarded to NAVIGEN, INC. in July, 2015 for $290,919.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43DA039601-01	Phase I	290,919	July 1, 2015	sbir.gov/node/1044475
‌ NAVIGEN, INC. SBIR Phase I Award, May 2015	A SBIR Phase I contract was awarded to NAVIGEN, INC. in May, 2015 for $597,344.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43AI120414-01	Phase I	597,344	May 1, 2015	sbir.gov/node/1029261
‌ NAVIGEN, INC. SBIR Phase II Award, July 2017	A SBIR Phase II contract was awarded to NAVIGEN, INC. in July, 2017 for $1,706,740.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44HL127886-02A1	Phase II	1,706,740	July 1, 2017	sbir.gov/node/1306345
‌ NAVIGEN, INC. SBIR Phase I Award, April 2015	A SBIR Phase I contract was awarded to NAVIGEN, INC. in April, 2015 for $298,731.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43CA192545-01A1	Phase I	298,731	April 10, 2015	sbir.gov/node/1029627
‌ NAVIGEN, INC. SBIR Phase II Award, December 2012	A SBIR Phase II contract was awarded to NAVIGEN, INC. in December, 2012 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44AI095172-02	Phase II	3,000,000	December 12, 2012	sbir.gov/node/1031599
‌ NAVIGEN, INC. SBIR Phase I Award, April 2015	A SBIR Phase I contract was awarded to NAVIGEN, INC. in April, 2015 for $224,632.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43HL127886-01	Phase I	224,632	April 1, 2015	sbir.gov/node/1030777
‌ NAVIGEN, INC. SBIR Phase II Award, September 2017	A SBIR Phase II contract was awarded to NAVIGEN, INC. in September, 2017 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2SB1AI095172-05	Phase II	3,000,000	September 18, 2017	sbir.gov/node/1321049
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $140,000.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43EY018968-01	Phase I	140,000		sbir.gov/content/inhibiting-pathologic-angiogenesis-and-vascular-leak-eye-0
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $592,068.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43AI098197-01	Phase I	592,068		sbir.gov/node/399678
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $299,392.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43AI095172-01A1	Phase I	299,392		sbir.gov/node/379050
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $147,660.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43HL091601-01	Phase I	147,660		sbir.gov/content/novel-therapeutic-approach-acute-lung-injury-0
‌ NAVIGEN, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to NAVIGEN, INC. for $1,270,720.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44EY018778-02	Phase II	1,270,720		sbir.gov/content/anti-htra1-therapy-amd-0
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $150,640.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43EY022516-01A1	Phase I	150,640		sbir.gov/node/677940
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $145,269.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43AR063509-01A1	Phase I	145,269		sbir.gov/node/677544
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $146,999.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43EY018778-01	Phase I	146,999		sbir.gov/content/targeting-htra-1-treatment-age-related-macular-degeneration-0
‌ NAVIGEN, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to NAVIGEN, INC. for $1,121,440.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	2R44HL091601-02	Phase II	1,121,440		sbir.gov/node/7845
‌ NAVIGEN, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to NAVIGEN, INC. for $557,531.0 USD from the U.S. Department of Health & Human Services.	‌ NAVIGEN, INC.		SBIR	1R43AI093083-01	Phase I	557,531		sbir.gov/content/novel-therapeutic-approach-sepsis-blocking-vascular-response-cytokine

Results per page:

27 results

0 selected

27 results

0 selected